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ABSTRACT
Introduction: While alpha-GPC (A-GPC) has received recent praise as a mental and
physical performance enhancement supplement, very limited research on this topic
exist, and no current studies examine A-GPC in collegiate-aged trained individuals. This
study hopes to bridge the gap in the current research literature on the topic of A-GPC
ingestion in young healthy adults in the cognitive and anaerobic paradigms.
Purpose: To investigate and identify the acute effects of A-GPC ingestion on
performance testing (hand-grip strength, jump height, power output/rate of force
development, mood, & reaction time) of college-aged recreationally trained individuals.
Methods: This study utilized a random, double-blinded, cross over design in which 27
participants (m=15; f=12) ingested either the placebo (dextrose, Group 1) A-GPC (6
mg·kgˉ¹ body mass, Group 2). Baseline measurements were obtained on the initial visit.
On supplemental visits, immediately following ingestion, subjects were required to sit in
a rested state for 25-minutes. Subjects first completed the 4-item mood questionnaire
to assess subjective feelings of energy, fatigue, alertness and focus for tasking, followed
by the pre reaction-time (RT) test. Body composition was then measured via the Bod
Pod, followed by a standardized questionnaire indicating age and training experience.
Each test consisted of four stations assessing physical task performance. Subjects
participated on three different occasions separated by 2-14 days.
Hypotheses: The author of this investigation predicted A-GPC would have a positive
impact on the performance variables, improving power output and neurological
stimulation. Furthermore, this study aimed to support preliminary evidence of the
ergogenic properties in A-GPC
Results: Twenty-seven total subjects participated in this study (Age: mean 21.66 ±SD
1.88 years; Height: mean 68.4 ±SD 4.1 inches; Weight: mean 169. 02 ±SD 32.2 lbs.; Body
fat: mean 19.2 ±SD 8.8%; Heart rate: mean 67.96 ±SD 8.2 beats/minute; SBP:
120.59±SD12.39 mmHg; DBP 74.74±SD 9.12 mmHg). There were no significant
differences between any of the variables pre to post testing. There were also no
differences between males and females for any test variable. Repeated measures
ANOVA: Multiple comparisons, LSD reveal statistical significances were found for the
following the dependent variables (fatigue, plyometric push-up, mood change, and
reaction-time test). Participants reported lower levels of fatigue following A-GPC
ingestion, yielding a significance of (p=0.019) when compared to baseline. The A-GPC
group showed increased levels of peak force production during the plyometric push-up
when compared to placebo with significance of (p=0.014). Mood change increased with
A-GPC ingestion compared to placebo with significance of (p=0.023); and subjects
scored more accurate (less incorrect answers) during the reaction-time test post A-GPC
ingestion compared to placebo (p=0.014).
Discussion: A-GPC supplementation showed a 12% increase in upper body power
output, and 12% improvement in accuracy during the reaction-time test. This
investigation supports A-GPC as an ergogenic aid for physical or cognitive stimulation.
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CHAPTER I
INTRODUCTION

Alpha-GPC
Alpha-glyceryl-phosphoryl-choline (A-GPC) supplementation has been shown to
improve mental and physical performance (Parker et al., 2015), increasing mood and
potentially power-output. While literature looks promising, only one pilot study exists
examining the acute effects of power-output (Ziegenfuss et al., 2008), with the
majority of literature on A-GPC being experimented on elderly persons and rodents.
Therefore, more research in young healthy adults is needed to support A-GPC as an
ergogenic aid (allowing the person to train with greater intensity for longer durations),
possibly increasing force production.
A-GPC is a choline containing phospholipid (Tayebati et al., 2013), an
intermediary of lecithin breakdown or simply lecithin molecule with two less fatty
acids (Zeisel, 1981). The supplement A-GPC is found as a naturally occurring
constituent of red meat products (Armah et al., 2008) and organ tissue (Schmidt et al.,
1945). However, it can be challenging to consume effective amounts in naturally
occurring sources (Zhang et al., 2012) therefore, it can be difficult to obtain enough AGPC in an individual’s diet to be beneficial, hence, supplementation may be necessary.
A-GPC is organically created from egg (Brockerhoff & Yurkoski, 1965) or soy lecithin
(Brownawell et al., 2011). When controlling the amount of choline in each supplement,
A-GPC requires 46% the dose of CDP-Choline (also known as citicoline) (Tayebati et al.,
1

2013). A-GPC revealed to be more effective, when tested by potency on a weight basis,
as a cholinergic, than both choline and CDP-choline when looking at serum values or
benefits from clinical research (Parnetti et al., 2007; Di Perri et al., 1991).
Evidence supports citicoline and choline as positively impacting cognitive
function, but little is known about either supplement’s impact on physical function.
The literature does contain some evidence that choline itself is vital to consider in
respect to endurance performance (Conlay et al., 1986; Penry & Manore et al., 2008)
revealing evidence of aerobic ergogenic properties in choline. One study reported that
a multi-ingredient supplement containing A-GPC improved mean power during
maximal effort sprint testing on a non-motorized treadmill (Jajim et al., 2015),
illustrating anaerobic properties in A-GPC as an ergogenic aid. However, common
performance tasks such as vertical jump and hand-grip strength (often used to assess
physical function ability in both athletic and non-athletic individuals) have not been
investigated.
Theoretically, with A-GPC being a more potent form of choline than citicoline, it
would be logical to assume the supplement would serve as a more effective additive to
physical performance efforts. Although A-GPC has been receiving recent praise as a
performance enhancing supplement for some physical (Stoppani, 2010; Bellar et al.,
2015; Ziegenfuss et al., 2008) and neurological aspects of human function (Scapicchio,
2013; Tomassoni et al., 2006), more research in human subjects on this topic is
needed.
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Of concern is that there is conflicting information in the literature regarding the
effects of A-GPC. For example, previous literature found that 30 minutes prior to
testing, A-GPC supplementation (4 mg·kgˉ¹) had no significant beneficial effect on
mood, cognitive function, and physiological performance (Parker et al., 2015).
Conversely, one study presented at the 2008 Annual Meeting Of The International
Society Of Sports Nutrition reported that trained men taking (6 mg·kgˉ¹) A-GPC 90minutes before workouts increased growth hormone (GH) levels by about 100% more
than placebo (Stoppani, 2010). The lone pilot study on power output found evidence,
that supplemental ingestion of A-GPC, given (6 mg·kgˉ¹) prior to a power test (bench
throws), reported a 14% power output improvement relative to a placebo when taken
45-minutes prior to activity (Ziegenfuss et al., 2008). These findings revealed
supplementation also increased post-exercise serum GH. In contrast, supplementation
showed no significant beneficial effect on peak power, rate of force development,
RMR, or cardiovascular hemodynamics, such as heart rate and blood pressure.
However, one study revealed A-GPC supplementation may augment lower body force
production. These findings reveal a 3% increase in lower body isometric strength,
following 6 days of acute A-GPC supplementation (Bellar et al., 2015). This contrast in
results supports the need for further investigations into A-GPC and its impact on
physiological performance.

3

Summary and Objectives
Previous claims support the idea that A-GPC as a supplement can boost
physical and mental performance; however, there is a gap in literature, noting only a
hand full of research exist on this topic in human subjects. Therefore, this study aims
to fill this gap in the literature, in regard to A-GPC as a power output and cognitive
supplement in young healthy adults. The purpose of this investigation was to identify
the acute effects of A-GPC in testing to placebo ingestion on jump height, hand-grip
strength, rate of force development, power output, mood change, and reaction time in
recreationally (moderately) trained, college-aged athletes. The author of this
investigation predicts A-GPC ingestion will improve physical task performance on jump
height, hand-grip strength, rate of force development, power output, mood, and
reaction time in moderately trained young healthy adults. Primarily, the author of this
study believed ergogenic properties in the supplement A-GPC exist, beneficially
influencing power output and enhanced brain function.

Limitations
Subjects were subjectively screened using questionnaires only. It’s possible a
physical by an MD with blood work may have revealed differences within and between
subjects possibly affecting the results. Not all performance tasks were utilized. It’s
possible different power tests and/or different reaction tests could elicit different
results. It’s possible different age groups and/or sub-groups (athletes, non-athletes,
pediatrics, geriatrics, etc.) could have responded differently.
4

Delimitations
This investigation only examined participants (18-26y) because there is
currently a large body of research in elderly persons and high number of college-aged
individuals. Subjects received body composition opposed to underwater weighing
because it is faster, and easier. The mood questionnaire assessed levels of energy,
fatigue, alertness, and focus; used to determine an individual’s mood because it was
easy and self-reported on a scale. Reaction time was measured to determine accuracy
and speed of response-time because it was a simple and easy for use. Hand-grip
strength was used via the hand-grip dynamometer, a good overall indicator of
strength, and easy to use. Standing vertical jump was measured to determine jump
height and peak force production via the jump mat over the VerTec for its accuracy
and simplicity. The plyometric push-up was tested to measure peak force production
where only one preliminary piece of literature has supported upper body power
output following A-GPC ingestion. Therefore, this investigation aims to bridge this gap
on the current literature with supportive evidence pertaining to power output.

5

CHAPTER II
LITERATURE REVIEW

Background
Choline is a precursor required to produce acetylcholine (Parnetti et al., 2007).
This is clinically valuable due to vast research suggesting learning, memory,
intelligence, and mood are stimulated in part by acetylcholine metabolism in neural
function (Hasselmo et al., 2006). L-alpha-glycerylphosphorylcholine (GPC) is a watersoluble, natural choline compound, deacylated phosphocreatine(PC) derivative, which
evidence supports effectiveness against the loss of membrane function in central
nervous system(CNS) injuries (Amenta et al. 1994).
Sangiorgi and colleagues (1994) noted, “GPC is a precursor molecule of the
neurotransmitter acetylcholine and was recently tested as a centrally acting
parasympathic precursor molecule of the neurotransmitter acetylcholine” (p. 253-69),
and evidence support it as a centrally acting parasympathominetic drug in dementia
disorders and acute cardio vascular diseases (De Jesus Moreno Moreno 2003). GPC
acts as a PC precursor and increases in uptake of membrane (Galazzini and Burg,
2009). This increased uptake of membrane-forming phospholipids, and PC exerted an
anti-inflammatory stimulation in previous investigational research (Chao et al, 1995,
El-Hariri et al. 1992). Parnetti and colleagues (2007) noted, “The deacylated, water
soluble PC analogue GPC rapidly delivers choline to the brain across the blood-brainbarrier (BBB)” (264-69). Another study found that pre-treatment with GPC is protective
6

against CNS irradiation-induced peripheral effects (Tőkés et al., 2014). GPC is a choline
donor compound where a recent experimental study revealed parasympathomimetic
action (Gibellini & Smith, 2010). This parasymphatomimetic action illustrates its
activation of the “rest and digest” division of the nervous system.
A-GPC has been shown to increase the release of neurotransmitter of
acetylcholine and facilitates learning and memory (Scapicchio, 2013). Another study
found higher acetylcholine production allows A-GPC to boost GH response to
weightlifting (Stoppani, 2010). One investigation observed the effects of A-GPC,
caffeine or placebo on markers of mood, cognitive function, power, speed, and agility,
where A-GPC prevented exercise-induced reductions in exhaustive levels (Parker et al.,
2015). The only current evidence supporting A-GPC supplementation as effective for
nootropic purposes in young healthy adults (18-35y) found A-GPC (Alpha BRAIN®)
ingestion improved recent verbal memory when compared to controls (Solomon et al.,
2016) as it appears to have cognitive improving properties. However, more research is
needed because no current evidence in humans can be found in the literature.
However, previous investigations supported A-GPC intake in rodents (Lopez et al.,
1991; Amenta et al., 2001; Trabucchi et al., 1986; Abbiati et al., 1993). More evidence
supports A-GPC supplementation on neuroprotective properties for ischemia attack, or
stroke patients (Zhang et al., 2013; Kidd et al., 2009). Other findings reveal A-GPC may
decrease the rate of cognitive decline when consuming (1200mg) of A-GPC daily
(Scapicchio, 2013; Tőke´s et al., 2015). Zhang and colleagues (2013) noted, “Plasma
choline increased 30-130 minutes’ post-ingestion (spikes at 60 minutes)” (p. 96-103)
7

and returns to baseline at 4 hours (Kawamura et al., 2012) with A-GPC
supplementation. A-GPC in Europe currently is being used as treatment of head
trauma and other acute brain injuries in addition to stroke (Onishchenko et al., 2008).

Primary Studies
Preliminary evidence found A-GPC may be beneficial for power output,
revealing a 14 % increase on bench throws in men with two years of training
experience (Ziegenfuss et al., 2008), when consuming (6 mg·kgˉ¹) of A-GPC 45-minutes
prior to exercise; this being the lone experimental study on power output following AGPC consumption. Although the ergogenic properties in A-GPC look promising, more
research is required to validate this evidence.
Stoppani (2010) found evidence that A-GPC consumption of (6 mg·kgˉ¹) 90minutes before exercise increased growth hormone levels by about 100% more than
placebo. Another study revealed evidence that A-GPC ingestion enhances strength,
particularly in the lower body after six days of administration when taking (6 mg·kgˉ¹)
of A-GPC 60-minutes prior to physical activity (Bellar et al., 2015). Other literature also
found when taking (6 mg·kgˉ¹) of A-GPC prior to physical activity that acute
supplementation was shown to augment bench press in a small sample of men with 2
years of training experience (Ziegenfuss et al., 2015). One study found (4 mg·kgˉ¹) of AGPC 30-minutes before exercise prevents exercise induced reductions in choline levels,
increases endurance performance and GH secretion (Parker et al., 2015). (See Table 1
for previous studies on acute supplementation of A-GPC).
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The most recent study evaluating the effects of A-GPC on physical and
psychomotor performance found A-GPC (2.5 mg·kgˉ¹) consumption prior to exercise
improved maximal velocity and maximum mechanical power on counter movement
jump (Marcus et al., 2017). Based on previous literature regarding A-GPC, it seems
logical for the supplement to be at least considered as an emerging ergogenic aid.

Table 1: Previous Studies on Alpha-GPC
Investigator
Nutrient Timing
Stoppani, 2010

(6 mg·kgˉ¹) 90-min

Ziegenfuss et al, 2008

(6 mg·kgˉ¹) 90-min

Bellar et al., 2015

(6 mg·kgˉ¹) 60-min

Parker et al., 2015

(4 mg·kgˉ¹) 30-min

Marcus et al., 2017

(2.5 mg·kgˉ¹) 120-min

Hoffman et al., 2010

(1.5 mg·kgˉ¹) 10-min

Findings
Increased GH levels 100%
more than placebo
Improved p-output 14%
relative to placebo
Enhanced strength,
particularly in lower body
after 6-days of
administration
Prevents exercise induced
reductions in choline
levels, increases
endurance performance,
and growth hormone
secretion
Improved maximal
velocity and mechanical
power on counter
movement jump
Prevent exercise-induced
decline in subjective
feelings of focus and
alertness following
exhaustive exercise

Reaction time was maintained post-exhaustive exercise (Parker et al., 2015). A
study by Parker and colleagues (2015) found “acute supplementation with A-GPC had
no statistically significant beneficial effect on measures of mood, cognitive function, or
physiological performance, in part due to large individual variability between subjects”
9

(p. 41). However, A-GPC seemed to improve physical and mental performance tasks.
(See Figure 1 for a recent study on A-GPC and Caffeine).

Figure 1: The effects of alpha-GPC-L (+8.5%), alpha-GPC-H (7.5%), and caffeine
(+2.0%), in comparison to placebo, on vertical jump peak power (in watts) (Parker et
al., 2015)

Growth Hormone Response to A-GPC
Ceda and company (1992) noted, “Growth hormone secretion in response to
stimulation (via GHRH) is amplified with administration of A-GPC, and although it can
be effective in both young and elderly it appears that elderly persons require a greater
relative increase, due to having less output initially” (p. 119-21). A-GPC’s primary
target is to augment the growth-hormone response to exercise, which can
subsequently induce the release of the anabolic hormone insulin-like growth factor-1,
which alone is enough to make A-GPC a valuable supplement (Barr, 2010). A-GPC
10

ingestion (3-6 mg·kgˉ¹) of may be beneficial for power output and act as an ergogenic
aid (Ziegenfuss et al., 2008).
Previous literature found A-GPC was able to maintain reaction time in humans
following exhaustive exercise (Hoffman et al., 2010). One study illustrated A-GPC
provided evidence for power output improvements following ingestion for upper body
force production during bench throws (Ziegenfuss et al., 2008). Another study found
increases in lower body strength but failed to find evidence for improved upper-body
strength during isometric testing. A-GPC seems promising however; more evidence is
required to validate the ergogenic effects of acute supplementation. A-GPC has shown
to augment acetylcholine levels in neurons in rat CNS (Traini et al., 2013). More
research needed to determine the neurological and physical properties of A-GPC in
human subjects. No studies look at chronic hormone spikes from A-GPC
supplementation. One study revealed A-GPC supplementation may augment lower
body force production. These findings reveal a 3% increase in lower body isometric
strength, following 6 days of acute A-GPC supplementation (Bellar et al., 2015).
Therefore, athletic trainers and sport professionals may consider adding A-GPC to the
diet of athletes to improve muscle performance. This investigation hopes to shed new
light on these contradictive findings for upper body power output during the
plyometric push-up.
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Nutrient Interactions
Previously literature claim A-GPC may have a synergistic effect with caffeine
(Bruce et al., 2014). Uridine may be effective in supplemental form to increase brain
GPC concentrations (Agarwal et al., 2018), but contradictive findings reveal this may
not be the case (Silveri et al., 2008). The current literature gives mixed evidence on the
influence A-GPC has on interacting with iron. One study found A-GPC supplementation
improved absorption of nonheme iron from food products comparable to that of
vitamin C when given at 2:1 ratio (Armah et la., 2008). However, another study failed
to find evidence supporting this theory when doubling the ratio to 4:1 (Troesch et al.,
2009).

Performance Testing
Mood Questionnaire. The 4-item mood questionnaire was created to assess
subjective feelings of energy, fatigue, alertness and focus for tasking (Hoffman et al.,
2010) consisting of a 10-point rating scale by verbal selection according to previously
used methods. Specifically, subjects were asked to rate their response using verbal
cues on a scale of a 1-10 which corresponded from 1= very low to 10 = very high. One
previous study found acute ingestion of an A-GPC containing supplement can prevent
the exercise-induced decline in subjective feelings of focus, and alertness in healthy
college students following exhaustive exercise (Hoffman et al., 2010). Although
cognitive influencing properties of A-GPC seem promising, more research is required
to clarify these nootropic benefits.
12

Hand Grip Strength
The purpose of this test was to measure the maximum isometric strength of
the hand and forearm muscles and is a good overall indicator of strength. A handgrip
dynamometer needed to perform this assessment. Currently there has been research
examining the acute effects A-GPC supplementation has on hand-grip strength and this
investigation is the first to look at these variables. (See Appendix A for figure).

Standing Vertical Jump Test
The purpose of this test was to assess average jump height and peak jump
performance. Vertical jump was recorded using the Just Jump via force plates to
examine rate of force development and peak force production. Previous literature
found improvement during the counter movement jump following A-GPC ingestion
(Marcus et al., 2017). (See Appendix A for illustration)

Plyometric Push-up
The purpose of the plyometric push-up was to assess impulse and rate of force
development. This test determines how much upper extremity force one can produce
and how fast the individual can produce it. While only a preliminary piece of literature
exists, giving evidence on improved power output (Ziegenfuss et al., 2008) following AGPC ingestion. Another study (Bellar et al., 2015) found no evidence to support upper
body power output post A-GPC consumption. Therefore, this investigation hopes to
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shed new light on these contradictive findings following A-GPC ingestion on upper
body power output. (See Appendix A for execution during the plyometric push-up).

Reaction-time Test
Reaction-time test using PsychoPy-Psychology software for Python (V1.82)
determined reaction time in participants. This is a computer-based reaction time test
that allows for custom programming. It also has the ability to program multiple
scenarios, preventing errors from participants memorizing patterns of other reactionbased tests (Peirce, 2007). The purpose of this test, originally written by Peirce as a
proof of concept – is that a high-level scripting language could generate experimental
stimuli in real time. Previous literature indicated acute ingestion of a supplement
containing A-GPC can prevent induced-decline of reaction time in healthy college
student’s following exhaustive exercise (Hoffman et al., 2010). However, limited
studies exist examining reaction time following A-GPC ingestion and more research is
needed to support the current evidence. (See Appendix A for figures of the reactiontest).

Summary
This examination explores the influence of A-GPC in various anaerobic
paradigms with particular attention given to the impact on performance variables.
While there are lots of promise regarding A-GPC as a supplement to boost physical and
mental performance, there is currently not enough literature examining A-GPC to
14

make this conclusion. Therefore, this study aims to fill the gap in the literature, in
regard to A-GPC as a power output and cognitive supplement for college-aged
individuals. The purpose of this investigation was to identify the acute effects of A-GPC
in testing to placebo ingestion on jump height, hang-grip strength, power output,
mood change, and reaction time in recreationally (moderately) trained, college-aged
athletes. The author of this investigation predicts A-GPC ingestion will improve
physical task performance on the aforementioned variables, benefiting cognitive
function and power output. Currently only one piece of literature examines the acute
effects A-GPC ingestion has on power output, where the population was men (30.1 ±
7y) with two years of training experience (Ziegenfuss et al., 2008). Therefore, this
research investigation was designed in efforts to bridge the gap in the current dearth
of literature, in hopes to shed new light on A-GPC as a power output supplement one
can use as an ergogenic aid to enhance strength via anaerobic paradigms, as well as
stimulate cognitive facilitation, improving mood and reaction time in young healthy
moderately trained adults.

15

CHAPTER III
METHODOLOGY

Inclusion/Exclusion
The following inclusion criteria was established: College aged (18-26),
recreationally (moderately) trained, healthy volunteer (resting BP under 140/90
mmHg, resting HR < 100 bpm). According to the American College of Sports Medicine
(Thompson et al., 2010), moderate training includes aerobic activity performed for a
minimum of 30-min five times a week. Health history was assessed using a
standardized university form to ensure that all applicants met the current standards
and regulations of being a healthy participant in order to participate in the trials.
Subjects were excluded from the study if the individual was untrained in recreational
related activities (did not meet the aforementioned requirements of being
recreationally trained); unhealthy (did not meet aforementioned requirements of
being a healthy volunteer); or had a resting BP over 140/90 mmHg and/or a resting HR
< 100 bpm.
This research project took place in a university exercise physiology lab, where
35 subjects were recruited to participate in the study. Twenty-seven subjects
completed all three visits looking at the acute effects of A-GPC on performance
enhancement.
Prospective participants were recruited via recruitment letters and emails sent
by the primary investigator. The cover letter and email briefly explained information
16

about how the participant was identified to receive the letter; who was responsible for
conducting the study and why; the study procedures; overview of any risks or potential
benefits; contact information; and proper notification about the confidentiality issues
associated with email communication.

Research Procedures
Study Design. The study utilized a random, double-blinded, cross over design
where subjects reported to the laboratory on three different occasions with each visit
separated by 2-14 days. All subjects read and signed the informed consent application
prior the initial familiarization trial, which included instructions on how to complete a
24-hour food log, height and weight measurements, body plethysmography via BOD
POD (Cosmed, USA), mood questionnaire, reaction time test, hand-grip strength,
standing vertical jump, and the plyometric push-ups. Upon arrival to the testing facility
and completion of informed consent procedures, subjects performed a brief
standardized dynamic warm-up in preparation for physical activity.
Following the dynamic warm-up, subjects were directed through the
performance testing protocol where stations were structured in the following order;
mood questionnaire, reaction-time test, hand-grip strength, standing vertical jump,
and plyometric push-up (See Table 2 for procedure outline, Figure 2 for schematic of
stations and Appendix 1 for descriptions of each maneuver).
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Table 2: Procedure Outline
Baseline Visit
Height
Mood Questionnaire/
Reaction-Time Test-PRE
Blood Pressure/ Heart Rate/
Body Composition
Reaction-Time Test-PRE
Hand-Grip Strength
Warm-Up
Standing Vertical Jump
Plyometric Push-Ups
Mood Questionnaire-POST
Reaction-Time Test-POST

Placebo Visit
Ingestion
Mood Questionnaire-PRE

A-GPC Visit
Ingestion
Mood Questionnaire-PRE

Reaction-Time Test-PRE

Reaction-Time Test-PRE

Body Composition/ Heart
Rate/ Blood Pressure
Hand-Grip Strength
Warm-Up
Standing Vertical Jump
Plyometric Push-Ups
Mood Questionnaire-POST
Reaction-Time Test-POST

Body Composition/ Heart
Rate/ Blood Pressure
Hand-Grip Strength
Warm-Up
Standing Vertical Jump
Plyometric Push-Ups
Mood Questionnaire-POST
Reaction-Time Test-POST

The subjects and research assistants who supervised the stations of the test
were blind to the treatment. Subsequent testing sessions included the same
procedures; the only difference was subject randomization into one of two groups
prior to completing the testing stations. Group 1 (placebo trial) was required to
consume (Dextrose); Group 2 consumed 6 mg·kgˉ¹ (A-GPC group). All test subjects
were instructed to refrain from consuming food; caloric beverage and A-GPC
substances at least 8 hours prior to each trial; and instructed to come in on a fasted
state during testing days. Understanding nutrient-nutrient interaction between A-GPC
combined with either uridine, iron, or caffeine may potentially skew the results
(Troesch et al., 2009; Armah et al., 2008; Agarwal et al., 2018; Silveri et al., 2008).
Therefore, the participants were asked to come in on a fasted state before treatment
trials (visits 2 &3). Coming in on a fasted state requires the participants not consume
anything eight hours prior to supplement ingestion on the treatment trials, preventing
any possible unknown health-related risk or nutrient interaction that may exist.
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Subjects were asked to continue current training throughout the duration of the study.
However, subjects were instructed to abstain from hard training (exerting maximal
effort to exhaustion) for 24 hours prior to each visit. Similar to baseline testing, the
subjects completed blood pressure measurements, heart rate, mood questionnaire,
and reaction-time testing each visit. At the end of the third and final session, data
analysis compared the effects of the nutrient on physical task performance. Each trial
was administrated, conducted, and separated by 2-14 days.

Testing Procedure
Baseline/Familiarization (Pre-Treatment). Subjects underwent a baseline trial
during their first visit to the laboratory where subjects submitted a completed 24-hour
food log that listed all foods and beverages the subject consumed in the previous 24hours. This was used to replicate caloric and macronutrient intake for the 24-hours
prior to future trials. Subjects then completed baseline assessments for height, weight,
blood pressure, and heart rate, followed by guidance through a standardized warm-up
and completion of the aforementioned performance testing protocol. Subjects were
asked to come to the treatment visits in a fasted state and to abstain from hard
training for 24-hours prior to performance testing.

24-hour Food Log/Alpha-GPC Questionnaire/Health History
Subjects were provided with a list of foods and beverages that contained A-GPC
(See Appendix 3 for nutritional sources on A-GPC), and subjects were asked to refrain
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from consuming these foods for 24-h before exercise testing. Subjects were provided
with a 24-h food log before the first testing session, so each subject can replicate their
diet before each of the following testing sessions. Subjects reported regular
consumption of A-GPC via a questionnaire.

Equipment
Upon arriving to the laboratory, subjects first obtained baseline measurements
for blood pressure and heart rate using a digital blood pressure cuff (Omron, USA),
height was assessed using a tape measure from the base of the floor to the peak
height of the individual (i.e. “wall height”), weight and body fat percentage was
measured using body plethysmography via BOD POD (Cosmed, USA) following
ingestion. The BOD POD is highly accurate and can detect even small changes in body
fat and body mass (National Institute for Fitness & Sport, 2017). A digital blood
pressure cuff was used to determine BP and HR, and PychoPy-Psychology software
(Python, V1.82) was used to determine reaction time. The Just Jump Mat (Probotics,
INC: Huntsville, AL) was used to assess force kinetics and jump height, the digital handgrip dynamometer (Takei Scientific Instruments, Japan) assessed overall strength while
the force plates (Summit, INC) were used to determined peak force output and RFD
during the vertical jump and plyometric push-ups. The force plate data was interfaced
with a NI DAQ (national instruments) with custom written LabVIEW software (national
instruments).
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Treatment Protocol
Supplementation Administration (Dosage). Prior to testing, on the second and
third visits, subjects were randomly provided with a moderate dose of either A-GPC (6
mg·kgˉ¹) or the same dosage of placebo (dextrose). The samples were weighed and
placed in a cup and mixed with 10 ounces of water, assigned in a randomized fashion.
Test subjects consumed a different substance on each occasion, outside of the
baseline trial where no substance was ingested. Subjects were instructed to sit in a
rested state for 25-minutes following ingestion of either the supplement or placebo.
The assigned supplement was prepared and delivered to the laboratory by a member
of the research team outside of the testing facility. Each sample was labeled with the
subject’s name on a shaker bottle. These procedures were followed in order to
maintain the double-blind procedure. During placebo visits, subjects ingested a dose of
dextrose that was administered and calculated to increase plasma glucose
concentrations by <0.3 mmol. L-1. These amounts have been utilized in previous
literature and therefore were adopted for this current study (Anselme et al., 1992;
Schneiker et al., 2006; Bell et al., 2001; Stuart et al., 2005; Astorino et al, 2010; Paton
et al., 2010; Bellar et al., 2015; Stoppani, 2010; Ziegenfuss et al., 2008). The placebo
consisted of dextrose, which was designed to mimic the actual supplement in terms of
consistency for taste, texture, and color.
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Warm-up Protocol
Following the treatment protocol, prior to the testing battery, subjects were
directed through standardized dynamic warm-up station, consisting of 10 body weight
squats, and 10 push-ups, in preparation for physical activity. Subjects were assessed on
hand-grip strength, jump height, rate of force development, power output, mood, and
reaction-time.

Testing Protocol
Following a 25-minute passive rest period following ingestion of the
supplement or placebo, subjects performed a mood questionnaire. The mood
questionnaire was completed post-ingestion, directly before each reaction-time test.
The same researcher administered the questionnaires each time. Body composition,
blood pressure and heart rate measurements were then obtained. Subjects then
completed the warm-up protocol and participated in the performance test. The test
took place in the exercise physiology laboratory, designed with four stations assessing
physical task performance, specifically measuring hand-grip strength, jump height,
power output, mood, and reaction-time. (See Figure 2 for schematics of stations).
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Figure 2: Schematics of Stations

The primary investigator and research team inspected the testing area prior
and post each visit to ensure participant safety. Participants who noticed any
unordinary discomfort during the duration of the performance testing were
terminated from the study in order to limit any potential minimal risk. To help limit
muscle soreness and body fatigue, participants were asked to refrain from high
intensity exercise 24-hours leading up to each visit. Maximum efforts were taken to
ensure participant safety, limiting any potential health-related risk.

Reaction Time coding
When analyzing the reaction time test, the column titles indicate the different
combinations of manipulated variables. The first three letters indicate the flanker type.
Flankers are the shapes that appear on the left and the right of the target participants
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respond to. Con – congruent, which means the target is flanked by arrows that point
the same direction, like this <<<<< and this >>>>>. Inc – incongruent, which means the
target is flanked by arrows that point in the opposite direction, like this <<><< and like
this >><>>. The fourth through sixth letters indicate the cue type. The cue is what
appears right before the target and flankers. Val – Valid Cue, which means that the cue
appears at the same location as the target (above or below the central fixation cross).
Ori – Orienting Cue, which means that the cue appears at the center of the screen, but
does not indicate the location of the target. It just alerts the participant that the target
is about to appear. Non – No cue appears. The last letters indicate the dependent
variable. RT – response time, which is reported in seconds, and only includes trials with
accurate responses. Acc – proportion accurate. For example: ConValRT – congruent
flankers, valid cue, Response time; ConOriRT –congruent flankers, orienting cue,
Response time; ConNonRT – congruent flankers, no cue, response time; incValRT incongruent flankers, valid cue, Response time; incOriRT - incongruent flankers,
orienting cue, Response time; incNonRT - incongruent flankers, no cue, response time
and so forth.

Statistical Analysis
A statistical power analysis was performed prior to testing to determine the
adequate number of subjects needed to find a 10% difference in task performance
between the placebo and A-GPC ingestion. Using a beta level of 0.80 was used to
determine the probability of accepting the null hypothesis when it is false and an alpha
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level of 0.05 determined the probability of rejecting the null hypothesis when it is true,
and sample size was determined to be 11 subjects per group. Inter-rater reliability was
established for the assessment of HR, BP, and hand-grip strength. Utilizing a 2-way
mixed effect model and a consistency of agreement design (3, k), (ICC) intra-class
correlations coefficients were determined to be between .80-.98 for the metrics.
This investigation ran statistics on the continuous variables to determine mean
and standard deviation and frequencies and percentages for categorical variables.
Normality was examined using a Shapiro-Wilk test, which indicated the study variables
were not normally distributed (p≤0.05). Non-parametric Mann-Whitney-U rank sum
tests were performed to determine if a difference existed between pre and post
testing for the following variables (mood change, reaction-time test, hand-grip
strength, and jump height, upper and lower body rate of force development and peak
force production). Finally, in order to assess differences between the two
supplementation options and the study variables, a repeated measures analysis of
variance (RMANOVA) was performed. Multiple comparisons were assessed in a posthoc fashion using a least squared difference (LSD) procedure. Analyses were
performed using a using SPSS software (Version 24, IBM, Armonk, New York). The level
of significance was set at p< 0.05 for all comparisons. Data was normalized to baseline
results, change scores represented the difference between the supplementation trial
in comparison to the baseline.
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CHAPTER IV
RESULTS

Descriptive Statistics
Twenty-seven total subjects (m=15; f=12) participated in this study (Age: mean
21.66 ±SD 1.88 years; Height: mean 68.4 ±SD 4.1 inches; Weight: mean 169. 02 ±SD
32.2 lbs.; Body fat: mean 19.2 ±SD 8.8%; Heart rate: mean 67.96 ±SD 8.2 beats/minute;
SBP: 120.59±SD12.39 mmHg; DBP 74.74±SD 9.12 mmHg). Frequency and percentages
found 56% (m=15) of the participants in the study were males, and 44% (f=12) of the
subjects who completed the study were females. (See Table 3 for mean difference and
standard deviation results for demographics of the study).

Table 3: Descriptive Statistics
Age
HT
Mean
21.667
68.380
SD
1.881
4.106
Range
8
15
Minimum 19
60
Maximum 27
75
Count
27
27

BM
169.022
32.226
109.6
109.8
219
27

Bfperc
19.233
8.796
32.8
7.9
40.7
27

SBP
120.593
12.395
48
92
140
27

DBP
74.741
9.121
35
55
90
27

There were no statistically significant differences between any of the variables
pre to post testing. There were also no significant differences between males and
females for any test variable.
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Repeated measures ANOVA: Multiple comparisons, LSD
Results revealed statistical differences for the following dependent variables of
this study: fatigue, plyometric push-up peak force production, mood change, and
accuracy during the reaction-time test. When examining fatigue during the mood
questionnaire, the placebo and A-GPC groups reported lower levels of fatigue
compared to baseline (0.719 points, p ≤ 0.019). Peak force production during the
plyometric push-up was significantly greater (12% p ≤ 0.014) for A-GPC versus placebo
(Table 4). Subjects reported being in a better mood during the A-GPC group compared
to the placebo with a mean difference of 0.667 points (p ≤ 0.023) When looking at
accuracy on the reaction-time test, subjects scored with less incorrect answers with AGPC ingestion when compared to placebo (12%, p ≤ 0.014).

Table 4: Dependent Variables
Dependent
A-GPC
Mean
Variable
Treatment Difference
Compared
To:
Fatigue
Baseline
-0.719
points

Significance
(P Value)
0.019

95%
95%
Confidence
Confidence
Interval Level
Interval Level
(Lower Bound) (Upper Bound)
-1.314
-0.123

PP Peak

Placebo

-12%

0.014

-22%

-2.5%

Mood
Change

Placebo

0.667
points

0.023

0.092

1.241

RT-Test
Accuracy

Placebo

-12%

0.014

-22%

-2.5%
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CHAPTER V
DISCUSSION

Summary
The author of this investigation hypothesized that A-GPC would have positive
acute effects on the performance variables of this study, improving physical task
performance in college-aged recreationally trained athletes. When focusing on A-GPC
consumption, subjects reported lower levels of fatigue and positive change in mood on
the mood questionnaire post ingestion; increased force production during the plyometric
push-up and participants had less incorrect answers when receiving the A-GPC
supplement. These findings illustrate young healthy adults may benefit from A-GPC
ingestion if one is feeling fatigued, or before exercise (mentally or physically).
A-GPC may influence fatigue in athletes, by preventing exercise-induced
reductions in choline levels, increases endurance performance and growth hormone
secretion (Parker et al., 2015). One study reported a multi-ingredient supplement that
contained A-GPC during a maximal effort sprint test on a non-motorized treadmill but
did not find any changes in counter-movement performance peak or mean power
(Jagim et al., 2016). The current study demonstrated less fatigue occurred with A-GPC
ingestion, which is in line with these previous investigations. However, the fatigue was
reported by the subject in a qualitative manner and was not physiologically measured.
Therefore, this finding should be interpreted with caution until physiologic verification
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of less fatigue can be investigated. This evidence is in agreement with previous
literature (Hoffman et al., 2010), but more physiological evidence is needed.
While participants in this investigation reported feeling in a better mood
following A-GPC ingestion, one previous study reported no changes in mood after AGPC supplementation (Parker et al., 2015). It should be noted that although a
significant difference was found between supplement ingestion and mood, the
difference was less than 1 point on the Likert scale suggesting the mood improvement
may not be clinically meaningful.
A-GPC has been identified as a nutrient for the brain, otherwise known as a
nootropic. Previous literature supports this supplement for cognitive function and
mood enhancement (Hoffman et al., 2010), which would partially explain the
improvement in accuracy on the reaction-time test (12% increase in accuracy) and the
change in mood when subjects ingested A-GPC compared to the baseline in this study.
One previous investigation supports the results of this study indicating acute ingestion
of A-GPC can maintain reaction time, feelings of focus, alertness to both visual and
auditory stimuli following high-intensity bouts of exercise (Hoffman et al., 2010).
A-GPC ingestion yielded greater power output, creating more force production
(12% increase) during the plyometric push-up movement compared to baseline,
providing evidence that A-GPC may have ergogenic effects during upper body power
output. However, no lower body benefits were found during the vertical jump or handgrip strength test when compared to placebo or baseline trials. Previous literature
supports this evidence where one study found supplementation of A-GPC increased
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upper body power output by 14% (Ziegenfuss et al., 2008). While another investigation
supports lower body force production following acute A-GPC supplementation,
however, the same study found no improvements in upper body force production
(Bellar et al., 2015). These contradictive findings could be due to inter-individual
variability between differences in sample, responder’s vs non-responders etc.
However, more research is needed to determine the physical and cognitive benefits of
A-GPC

Future research in this area
Although this study supports A-GPC as an ergogenic aid, providing additional
evidence to contradictive literature on force production, more research is needed. This
investigation was the first to examine the acute effects A-GPC ingestion has on
cognitive facilitation (reaction-time test and mood questionnaire) and power output
(Hand-grip strength, standing vertical jump, and plyometric push-up) via anaerobic
paradigms in young healthy adults. A future study may focus on examining a collegiate
athletic program and the athletes by position to limit individual variability between
subjects. Although previous studies support the evidence found in this investigation,
further research is needed on this topic to clarify the benefits of A-GPC ingestion on
physical and mental performance in young healthy adults. Ziegenfuss and colleagues
(2008), noted, “Future work should examine how resistance exercise + A-GPC affect
the growth hormone-insulin growth factor axis and their associated family of binding
proteins” (p. 15). There is recent literature claiming citicoline and caffeine have a
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theoretical synergistic effect, although there is no evidence currently (Bruce et al,
2014), with A-GPC being a more potent form of choline, future research may want to
examine this synergist effect that could potentially exist between A-GPC and caffeine.
More research is needed to determine interactions between other nutrients such as
uridine (Agarwal et al., 2018; Silveri et al., 2008) and iron (Armah et al., 2008; Troesch
et al., 2009).

Conclusion
This study provides support, similar to previous literature, that A-GPC maybe
beneficial as a cognitive and power output supplement. Significance of the study
reveals a 12% increase in power output during the plyometric push-up and accuracy
during the reaction-time test. This study sheds new light on the potential benefits AGPC may have on young healthy adults and the ergogenic effects of A-GPC.
Specifically, A-GPC may improve trained college-aged individuals’ level of fatigue,
mood, force production, and reaction time. For college students, the amount of time
spent working and attending school may create challenges with expending and
managing energy requirements. A-GPC could potentially serve as a reasonable
supplement for young healthy adults attempting to deal with the stressors of everyday
life or for the student looking for an advantage academically or with physical activity.
Although future research is needed to give merit to these findings, A-GPC looks
promising in supplementation as an ergogenic aid or to help facilitate cognitive
function, promoting learning via enhanced memory recall.
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DESCRIPTION OF STATIONS

1. Hand Grip Strength
The purpose of this test is to measure the maximum isometric strength of the
hand and forearm muscles. Handgrip strength is important for any sport in
which the hands are used for catching, throwing or lifting. Also, as a general
rule people with strong hands tend to be strong elsewhere, so this test is
often used as a general test of strength. A handgrip dynamometer is needed
to perform this assessment. Following procedure: The subject holds the
dynamometer in the hand to be tested, with the arm at right angles and the
elbow by the side of the body. The handle of the dynamometer is adjusted if
required - the base should rest on first metacarpal (heel of palm), while the
handle should rest on middle of four fingers. When ready the subject
squeezes the dynamometer with maximum isometric effort, which is
maintained for about 5 seconds. No other body movement is allowed. The
subject should be strongly encouraged to give a maximum effort. The
position of the arm and hand can vary in different grip strength protocols.
Various positions include the elbow being held at right angles as per the
above procedure, the arm hanging by the side, and the extended arm being
swung from above the head to by the side during the squeezing motion.
The Eurofit Test Manual recommends squeezing for 3 seconds. The
procedure for the Groningen Elderly Tests has the subject hang their hand by
their side, one practice trial, best of three attempts with 30 seconds rest
between. Scoring, the best result from several trials for each hand is
recorded, with at least 15 seconds recovery between each effort.
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2. Standing Vertical Jump Test
(To assess average force on jumps and peak jump performance)
Vertical jump will be recorded using the Just Jump or Run mat. Participants
were instructed to jump and reach their maximum height. Just Jump or Run
mat is measured in units of 0.1 inches. Participants will not be allowed to
have a moving start. Each participant was given three attempts at the Just
Jump or Run mat. The purpose of this test is to measure the leg muscle
power. Equipment needed will be the jump mat. Procedure: Vertical jump
height can be measured using a jump mat, which measures the
displacement of the hips. To be accurate, you must ensure the feet land
back on the mat with legs nearly fully extended. The vertical jump is usually
performed with a countermovement, where there is bending of the knees
immediately prior to the jump. Scoring: the jump height will be recorded as
a distance score (possible conversions for jump height into a power or work
score may be calculated).

3. Plyometric Push-up Test
(To assess impulse and rate of force development)
During the plyometric push-ups (otherwise known as clap push-ups), the
participants will lower the chest, down toward the force plates, while
maintaining a straight line with their body. After this phase, the subject
would forcefully push up and while in the air clap their hands together (if
possible) before landing back onto the force plates. One full repetition was
defined as successfully completing both phases of the exercise and returning
to the starting position after landing back onto the force plates (Koch et al.,
2012). The subjects will be instructed to perform each repetition
consecutively with maximal explosiveness and no pause (rest) between
repetitions. After the completion of the 4 repetitions of each set. The
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standard modified push-up will be an alternative for subjects who cannot get
full extension and separation from the force plates.

4. Reaction-Time Test
Reaction-time test will be conducted using PsychoPy-Pyschology software
for Python V1.82. This is a computer based reaction time test that allows for
custom programming. It also has the ability to program multiple scenarios,
preventing errors from participants memorizing patterns of other reaction
based tests (Peirce, 2007). In 2003, PsychoPy was originally written by Peirce
as a proof of concept - that a high-level scripting language could generate
experimental stimuli in real time. Reaction-time will be assessed prior
ingestion and post-test, directly before each mood test. Each subject will
have a letter on the keyboard designated for left and right arrows which will
appear on the computer screen, with the index finger on each hand pressing
the key that represents the arrow as soon as the subject specifies the
direction of the arrow. Reaction-time test will be employed following the
mood questionnaire, post-ingestion, pre and post-test.
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FOOD SOURCES OF A-GPC


Toasted wheat germ (33.78mg/100g), wheat crackers (10.94mg/100g), and
wheat bread (4.93mg/100g)



Oat bran (33.25mg/100g)



2% Milk (9.98mg/100g) and skim milk (9.70mg/100g)



Cheese (2.30mg/100g), Cottage cheese (8.39mg/100g), Cream cheese
(9.26mg/100g)



Yogurt (7.79-9.10mg/100g)



Eggs (0.60mg/100g)



Chicken breast (1.12-1.20mg/100g) and liver (8.80mg/100g)



Pork sausage (7.41mg/100g), cooked pork loin (22.51mg/100g)



Beef liver (77.93mg/100g)



Atlantic cod (30.04mg/100g), Salmon (5.89mg/100g)



Bananas (5.60mg/100g), blueberries (0.61mg/100g), avocado (0.73mg/100g),
grapefruit (1.16mg/100g), cantaloupe (0.71mg/100g), oranges (1.10mg/100g),
and strawberries (0.86mg/100g)



Broccoli (1.32mg/100g), cabbage (3.47mg/100g), cucumber (0.48mg/100g),
spinach (0.21mg/100g), onions (0.57mg/100g), sauerkraut (0.94mg/100g),
sweet potatoes (1.97mg/100g), Russel sprouts (3.18mg/100g), and raw
mushrooms (5.11mg/100g)



Beer (light at 2.98mg/100g, regular at 5.06mg/100g) and coffee (0.67mg/100g)

Steven H. Zeisel2, Mei-Heng Mar, Juliette C. Howe*, and Joanne M. Holden (2003) The
American Society for Nutritional SciencesConcentrations of Choline Containing
Compounds and Betaine in Common Foods.
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Recruitment Letter
The Acute Effects of Alpha-GPC on Hand
Grip Strength, Jump Height, Rate of Force
Development, and Reaction-Time in
Recreationally Trained, College-Aged
Athletes
Researcher: Josey Lucas Cruse
College of Health Sciences
Department of Exercise and Sports Science at Eastern Kentucky University
Josey_cruse10@mymail.eku.edu
859-302-4443
Dear Potential Participant,
You are being invited to participate in a research study to examine the
ergogenic effect of strength and power training supplement, A-GPC, during physical
task performance. A-GPC is a supplement that has previously been researched and
proven to increase levels of acetylcholine in the blood and growth hormone secretion.
Increased levels of acetylcholine in the body have been shown to enhance strength
and explosive ability (power). Elevated levels of GH in the body have also been shown
to increase strength and explosive ability. Few studies have examined the effect of AGPC on sport performance. Therefore, your participation in this investigation hopes to
further the research literature on this topic, aiming to identify the acute effects of AGPC ingestion on Hand Grip Strength, Jump Height, Rate of Force Development, and
Reaction-Time in Recreationally Trained, College-Aged Athletes
For this study you will be asked to report to the exercise physiology lab in the
Moberly facility, on 3 separate occasions, separated by 2-7 days. You will be asked to
come at the same time for each testing. You will be provided with a list of foods and
beverages that contain A-GPC and asked to refrain from these foods. You will be asked
to abstain from hard training for at least 24 hours prior to each visit. Before and after
each visit you will be asked to perform a reaction-time test conducted using PsychoPyPyschology software (Python V1. 82.). Next, measurements for blood pressure, heart
rate, height and weight will be assessed, and body fat percentage will be determined
using the BOD POD.
After that, you will be asked to perform a series of physical performance tests
(4 stations, consisting of the hand grip strength, standing vertical jump, plyometric
push-ups, and reaction-time). First, you will perform the reaction-time test before
physical performance. Next you will be tested on hand grip strength using a dynometer, followed by the standing vertical jump test in which you will be asked to jump
as high as you can to test your lower body explosive ability will be assessed using the
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jump mat. Next, you will perform the plyometric push-ups on the force plate to assess
impulse and rate of force development.
Prior to testing, on the second and third visit, you will randomly be provided with a
moderate dose of either alpha-GPC (6 mg·kgˉ¹) or the same dosage of placebo
(dextrose), which will be weighed and placed in a cup and mixed with 10 ounces of
water and assigned in a randomized fashion. You will consume a different substance
on visit two and three, outside the baseline trial, where no substance will be ingested.
Subjects will be instructed to sit in a rested state for 45 minutes following ingestion of
either the supplement or placebo. The assigned supplement was prepared by an
outside member of the research staff and delivered to the laboratory with the
subject’s name on a shaker bottle in order to maintain a double-blind procedure.
If you chose to start this study, you should be aware that you will receive no
benefits such as extra credit or course credit in any College of Health Sciences course.
You may choose to stop the study at any time and will face no penalty. Your
participation is completely voluntary. The study will take approximately 5 hours of
your time over the course of 15 days, and you may experience some muscle soreness
as a result of the exercise.
The intention is to analyze the data after the study is complete and make a
report and publish in a scientific journal. Your name will not be part of any reporting of
any information from this study. The files from the study will be stored in an encrypted
file, on a password protected computer accessible only to Dr. Lane. If you have any
questions about this study, please contact either Josey Cruse at
josey_cruse10@mymail.eku.edu or Dr. Michael Lane at Michael.lane@eku.edu.
Respectfully,
Josey Cruse
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